blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2863918

EP2863918 - SALT CRYSTALS OF A PDE1 INHIBITOR [Right-click to bookmark this link]
Former [2015/18]SALT CRYSTALS
[2019/28]
StatusNo opposition filed within time limit
Status updated on  30.10.2020
Database last updated on 26.07.2024
FormerThe patent has been granted
Status updated on  22.11.2019
FormerGrant of patent is intended
Status updated on  19.11.2019
FormerExamination is in progress
Status updated on  04.11.2019
FormerGrant of patent is intended
Status updated on  01.07.2019
FormerExamination is in progress
Status updated on  20.07.2018
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Intra-Cellular Therapies, Inc.
430 East 29th Street, Suite 900
New York, NY 10016 / US
[2016/33]
Former [2015/18]For all designated states
Intra-Cellular Therapies, Inc.
3960 Broadway
New York, NY 10032 / US
Inventor(s)01 / LI, Peng
Intra-Cellular Therapies Inc.
3960 Broadway
New York, New York 10032 / US
02 / WENNOGLE, Lawrence P.
Intra-Cellular Therapies Inc.
3960 Broadway
New York, New York 10032 / US
03 / DAVIS, Robert
Intra-Cellular Therapies Inc.
3960 Broadway
New York, New York 10032 / US
04 / BUCKTON, Graham
5 Boulton Road
Reading Berkshire RG2 ONH / GB
05 / HOOPER, Mark
5 Boulton Road
Reading Berkshire RG2 ONH / GB
 [2015/18]
Representative(s)Chapman, Paul Gilmour, et al
Marks & Clerk LLP
40 Torphichen Street
Edinburgh EH3 8JB / GB
[2019/52]
Former [2015/18]Chapman, Paul Gilmour
Marks & Clerk LLP
Atholl Exchange
6 Canning Street
Edinburgh EH3 8EG / GB
Application number, filing date13806448.021.06.2013
[2019/52]
WO2013US47123
Priority number, dateUS201261662355P21.06.2012         Original published format: US 201261662355 P
[2015/18]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2013192556
Date:27.12.2013
Language:EN
[2013/52]
Type: A2 Application without search report 
No.:EP2863918
Date:29.04.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 27.12.2013 takes the place of the publication of the European patent application.
[2015/18]
Type: B1 Patent specification 
No.:EP2863918
Date:25.12.2019
Language:EN
[2019/52]
Search report(s)International search report - published on:US27.02.2014
(Supplementary) European search report - dispatched on:EP16.12.2015
ClassificationIPC:A61K31/519, A61P35/00, A61P9/00, C07D487/14
[2016/02]
CPC:
C07D487/14 (EP,IL,KR,RU,US); A61K31/519 (IL,KR,RU); A61P11/00 (EP,IL);
A61P15/00 (EP,IL); A61P15/08 (EP); A61P25/00 (EP,IL);
A61P25/14 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/20 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P27/06 (EP); A61P29/00 (EP); A61P35/00 (EP);
A61P43/00 (EP); A61P9/00 (EP,IL); A61P9/12 (EP);
C07C309/04 (US); C07C55/02 (US); C07C57/15 (US);
C07D487/04 (KR); C07B2200/13 (IL,US) (-)
Former IPC [2015/18]A61K31/519, A61P35/00, A61P9/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/18]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:SALZKRISTALLE VON EINEM PDE1-HEMMSTOFF[2019/28]
English:SALT CRYSTALS OF A PDE1 INHIBITOR[2019/28]
French:CRISTAUX DE SEL D'UN INHIBITEUR DE LA PDE1[2019/28]
Former [2015/18]SALZKRISTALLE
Former [2015/18]SALT CRYSTALS
Former [2015/18]CRISTAUX DE SEL
Entry into regional phase06.01.2015National basic fee paid 
06.01.2015Search fee paid 
06.01.2015Designation fee(s) paid 
06.01.2015Examination fee paid 
Examination procedure06.01.2015Examination requested  [2015/18]
21.07.2016Amendment by applicant (claims and/or description)
24.07.2018Despatch of a communication from the examining division (Time limit: M02)
03.10.2018Reply to a communication from the examining division
05.02.2019Despatch of a communication from the examining division (Time limit: M04)
27.05.2019Reply to a communication from the examining division
02.07.2019Communication of intention to grant the patent
31.10.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
31.10.2019Fee for grant paid
31.10.2019Fee for publishing/printing paid
19.11.2019Information about intention to grant a patent
19.11.2019Receipt of the translation of the claim(s)
Divisional application(s)EP19219516.2  / EP3733675
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  24.07.2018
Opposition(s)28.09.2020No opposition filed within time limit [2020/49]
Fees paidRenewal fee
10.06.2015Renewal fee patent year 03
10.06.2016Renewal fee patent year 04
16.06.2017Renewal fee patent year 05
11.06.2018Renewal fee patent year 06
13.06.2019Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.06.2013
AL25.12.2019
CY25.12.2019
CZ25.12.2019
EE25.12.2019
FI25.12.2019
HR25.12.2019
LT25.12.2019
LV25.12.2019
MC25.12.2019
MK25.12.2019
MT25.12.2019
RO25.12.2019
RS25.12.2019
SI25.12.2019
SK25.12.2019
SM25.12.2019
BG25.03.2020
NO25.03.2020
GR26.03.2020
IS25.04.2020
PT20.05.2020
LU21.06.2020
[2022/32]
Former [2022/27]HU21.06.2013
AL25.12.2019
CY25.12.2019
CZ25.12.2019
EE25.12.2019
FI25.12.2019
HR25.12.2019
LT25.12.2019
LV25.12.2019
MC25.12.2019
MT25.12.2019
RO25.12.2019
RS25.12.2019
SI25.12.2019
SK25.12.2019
SM25.12.2019
BG25.03.2020
NO25.03.2020
GR26.03.2020
IS25.04.2020
PT20.05.2020
LU21.06.2020
Former [2021/15]AL25.12.2019
CZ25.12.2019
EE25.12.2019
FI25.12.2019
HR25.12.2019
LT25.12.2019
LV25.12.2019
MC25.12.2019
RO25.12.2019
RS25.12.2019
SI25.12.2019
SK25.12.2019
SM25.12.2019
BG25.03.2020
NO25.03.2020
GR26.03.2020
IS25.04.2020
PT20.05.2020
LU21.06.2020
Former [2021/12]AL25.12.2019
CZ25.12.2019
EE25.12.2019
FI25.12.2019
HR25.12.2019
LT25.12.2019
LV25.12.2019
MC25.12.2019
RO25.12.2019
RS25.12.2019
SI25.12.2019
SK25.12.2019
SM25.12.2019
BG25.03.2020
NO25.03.2020
GR26.03.2020
IS25.04.2020
PT20.05.2020
Former [2020/51]AL25.12.2019
CZ25.12.2019
EE25.12.2019
FI25.12.2019
HR25.12.2019
LT25.12.2019
LV25.12.2019
RO25.12.2019
RS25.12.2019
SI25.12.2019
SK25.12.2019
SM25.12.2019
BG25.03.2020
NO25.03.2020
GR26.03.2020
IS25.04.2020
PT20.05.2020
Former [2020/40]AL25.12.2019
CZ25.12.2019
EE25.12.2019
FI25.12.2019
HR25.12.2019
LT25.12.2019
LV25.12.2019
RO25.12.2019
RS25.12.2019
SK25.12.2019
SM25.12.2019
BG25.03.2020
NO25.03.2020
GR26.03.2020
IS25.04.2020
PT20.05.2020
Former [2020/37]AL25.12.2019
CZ25.12.2019
EE25.12.2019
FI25.12.2019
HR25.12.2019
LT25.12.2019
LV25.12.2019
RO25.12.2019
RS25.12.2019
SK25.12.2019
SM25.12.2019
BG25.03.2020
NO25.03.2020
GR26.03.2020
PT20.05.2020
Former [2020/36]AL25.12.2019
CZ25.12.2019
EE25.12.2019
FI25.12.2019
HR25.12.2019
LT25.12.2019
LV25.12.2019
RO25.12.2019
RS25.12.2019
BG25.03.2020
NO25.03.2020
GR26.03.2020
PT20.05.2020
Former [2020/35]AL25.12.2019
CZ25.12.2019
FI25.12.2019
HR25.12.2019
LT25.12.2019
LV25.12.2019
RO25.12.2019
RS25.12.2019
BG25.03.2020
NO25.03.2020
GR26.03.2020
Former [2020/32]AL25.12.2019
FI25.12.2019
HR25.12.2019
LT25.12.2019
LV25.12.2019
RS25.12.2019
BG25.03.2020
NO25.03.2020
GR26.03.2020
Former [2020/25]FI25.12.2019
HR25.12.2019
LT25.12.2019
LV25.12.2019
RS25.12.2019
BG25.03.2020
NO25.03.2020
GR26.03.2020
Former [2020/23]FI25.12.2019
LT25.12.2019
LV25.12.2019
BG25.03.2020
NO25.03.2020
GR26.03.2020
Former [2020/22]FI25.12.2019
LT25.12.2019
BG25.03.2020
NO25.03.2020
Former [2020/21]NO25.03.2020
Cited inInternational search[Y]US2008188492  (LI PENG [US], et al);
 [Y]US2010273754  (LI PENG [US]);
 [A]US2011237561  (LI PENG [US], et al);
 [A]US2012071450  (LI PENG [US], et al);
 [AP]US2012238589  (LI PENG [US])
by applicantWO2006133261
 WO2009075784
 US2010273754
 WO2010132127
 WO2011153129
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.